Donor Clonal Hematopoiesis Increases Risk of Acute Graft Versus Host Disease after Matched Related Transplantation in AML and MDS Patients.

IF 23.1 1区医学 Q1 HEMATOLOGY Blood Pub Date : 2019-11-13 DOI:10.1182/blood-2019-127195

B. Oran, R. Champlin, Feng Wang, Nikeshan Jeyakumar, G. Garcia-Manero, H. Kantarjian, R. Saliba, K. Cao, E. Shpall, A. Alousi, R. Mehta, U. Popat, A. Futreal, Koichi Takahashi

{"title":"Donor Clonal Hematopoiesis Increases Risk of Acute Graft Versus Host Disease after Matched Related Transplantation in AML and MDS Patients.","authors":"B. Oran, R. Champlin, Feng Wang, Nikeshan Jeyakumar, G. Garcia-Manero, H. Kantarjian, R. Saliba, K. Cao, E. Shpall, A. Alousi, R. Mehta, U. Popat, A. Futreal, Koichi Takahashi","doi":"10.1182/blood-2019-127195","DOIUrl":null,"url":null,"abstract":"DISCLOSURES\nOran: AROG pharmaceuticals: Research Funding; Astex pharmaceuticals: Research Funding. Champlin:Sanofi-Genzyme: Research Funding; Actinium: Consultancy; Johnson and Johnson: Consultancy. Garcia-Manero:Amphivena: Consultancy, Research Funding; Helsinn: Research Funding; Novartis: Research Funding; AbbVie: Research Funding; Celgene: Consultancy, Research Funding; Astex: Consultancy, Research Funding; Onconova: Research Funding; H3 Biomedicine: Research Funding; Merck: Research Funding. Kantarjian:Amgen: Honoraria, Research Funding; Agios: Honoraria, Research Funding; BMS: Research Funding; Jazz Pharma: Research Funding; Novartis: Research Funding; Actinium: Honoraria, Membership on an entity's Board of Directors or advisory committees; Takeda: Honoraria; Ariad: Research Funding; Daiichi-Sankyo: Research Funding; Astex: Research Funding; Cyclacel: Research Funding; Immunogen: Research Funding; Pfizer: Honoraria, Research Funding; AbbVie: Honoraria, Research Funding. Popat:Jazz: Consultancy; Incyte: Research Funding; Bayer: Research Funding. Takahashi:Symbio Pharmaceuticals: Consultancy.","PeriodicalId":9102,"journal":{"name":"Blood","volume":"134 Supplement_1 1","pages":"47"},"PeriodicalIF":23.1000,"publicationDate":"2019-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1182/blood-2019-127195","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 4

Abstract

DISCLOSURES Oran: AROG pharmaceuticals: Research Funding; Astex pharmaceuticals: Research Funding. Champlin:Sanofi-Genzyme: Research Funding; Actinium: Consultancy; Johnson and Johnson: Consultancy. Garcia-Manero:Amphivena: Consultancy, Research Funding; Helsinn: Research Funding; Novartis: Research Funding; AbbVie: Research Funding; Celgene: Consultancy, Research Funding; Astex: Consultancy, Research Funding; Onconova: Research Funding; H3 Biomedicine: Research Funding; Merck: Research Funding. Kantarjian:Amgen: Honoraria, Research Funding; Agios: Honoraria, Research Funding; BMS: Research Funding; Jazz Pharma: Research Funding; Novartis: Research Funding; Actinium: Honoraria, Membership on an entity's Board of Directors or advisory committees; Takeda: Honoraria; Ariad: Research Funding; Daiichi-Sankyo: Research Funding; Astex: Research Funding; Cyclacel: Research Funding; Immunogen: Research Funding; Pfizer: Honoraria, Research Funding; AbbVie: Honoraria, Research Funding. Popat:Jazz: Consultancy; Incyte: Research Funding; Bayer: Research Funding. Takahashi:Symbio Pharmaceuticals: Consultancy.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

供体克隆造血增加AML和MDS患者匹配相关移植后急性移植物抗宿主病的风险

披露：AROG制药：研究资助；Astex制药：研究资助。尚普林：赛诺菲基因：研究资助；锕：咨询；Johnson and Johnson：咨询。Garcia Manero：《两栖动物：咨询、研究资助》；Helsinn：研究资助；诺华：研究基金；AbbVie：研究资助；Celgene：咨询、研究资助；Astex：咨询、研究资助；Onconova：研究资助；H3生物医学：研究资助；默克：研究资助。Kantarjian：安进：Honoria，研究基金；Agios：荣誉奖，研究资助；BMS：研究资助；爵士制药：研究资助；诺华：研究基金；锕：Honoria，实体董事会或咨询委员会成员；武田：Honoria；Ariad：研究资助；Daiichi Sankyo：研究资助；Astex：研究资助；Cyclacel：研究资助；免疫原：研究资助；辉瑞：Honoria，研究基金；AbbVie：荣誉，研究基金。流行音乐：爵士乐：咨询；Incyte：研究资助；拜耳：研究基金。高桥：Symbio制药：咨询。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Blood 医学-血液学

CiteScore

23.60

自引率

3.90%

发文量

955

审稿时长

1 months

期刊介绍： Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy scope; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate.

期刊最新文献

De novo CD19- B-ALL: awareness of a rare entity in initial diagnosis. Glutathionylated leaky mitochondrial pores as target in AML. Dysbiosis and gastrointestinal GVHD: to treat or not to treat. A viral Achilles' heel for EBV-positive lymphomas. Pediatric hospital-acquired thrombosis: time for a CHAT.